Skip to main content

Advertisement

SpringerLink
Log in

Effect of Colitis and Ileoanal Pouch on Biliary Enrichment of Ursodeoxycholic Acid in Primary Sclerosing Cholangitis

  • Pancreatic and Biliary Disorders
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

In primary sclerosing cholangitis (PSC), biliary enrichment of ursodeoxycholic acid (UDCA) may represent the decisive factor for its presumable beneficial effect. Up to now it is not clear how colitis and colectomy with ileo-anal pouch affect the biliary enrichment of UDCA and the biliary bile acid composition. We determined the biliary bile acid composition in 63 patients with PSC including 7 patients with ileo-anal pouch, 31 patients with colitis, and 25 patients without colitis. No differences existed between patients with and those without colitis. In patients with colectomy and pouch at a UDCA dose of 17.7 ± 1.6 mg/kg (n = 7), biliary UDCA represented 46.4 ± 6.7% (mean ± SD) of total bile acids. An increase in the dose in six pouch patients from 12.5 ± 0.9 to 22.3 ± 1.6 mg/kg led to a slight increase in biliary enrichment of UDCA, from 39.8 ± 8.1 to 49.4 ± 10.7%. In five of seven patients with ileo-anal pouch, biliary UDCA enrichment was within the normal range, and in two of seven it was permanently or intermittently abnormally low. During UDCA treatment, in pouch patients the biliary content of deoxycholic acid and lithocholic acid was reduced, whereas all other bile acids were unchanged. In a minority of patients with ileo-anal pouch, biliary enrichment of UDCA may be markedly reduced, whereas patients with colitis have a biliary UDCA enrichment not different from that of patient without colitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Poupon RE, Balkau B, Eschwege E, Poupon R: A multicenter controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 324:1548–1554, 1991

    CAS  PubMed  Google Scholar 

  2. Lindor KDL, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, Wiesner RH, Anderson ML, Lange SM, Lesage G, Rossi SS, Hofmann AF: Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 106:1284–1290, 1994

    CAS  PubMed  Google Scholar 

  3. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ: Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 113:884–890, 1997

    Article  CAS  PubMed  Google Scholar 

  4. Beuers U, Spengler U, Kruis W, Aydemir Š, Wiebecke B, Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Paumgartner G: Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo controlled trial. Hepatology 16:707– 714, 1992

    CAS  PubMed  Google Scholar 

  5. Lindor KD, Mayo PSC/UDCA Study Group: Ursodiol for the treatment of primary sclerosing cholangitis. N Engl J Med 336:691–695, 1997

    Article  CAS  PubMed  Google Scholar 

  6. Stiehl A, Rudolph G, Sauer P, Benz C, Stremmel W, Walker S, Theilmann L: Efficacy of ursodeoxycholic acid and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol 26:560–566, 1997

    Article  CAS  PubMed  Google Scholar 

  7. Mitchell SA, Bansi DS, Hunt N, von Bergmann K, Fleming KA, Chapman RW: A preliminary trial of high dose ursodeoxycholic acid in primary sclerosing cholangitis: Results of a randomized double-blind placebo-controlled study. Gastroenterology 121:900–907, 2001

    Article  CAS  PubMed  Google Scholar 

  8. Stiehl A, Rudolph G, Kloeters-Plachky P, Sauer P, Walker S: Development of dominant bile duct stenoses in patients with primary aclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 36:151–156, 2002

    PubMed  Google Scholar 

  9. Stiehl A, Raedsch R, Rudolph G: Ileal excretion of bile acids: comparison with biliary bile acid composition and effect of ursodeoxycholic acid treatment. Gastroenterology 94:1201–1206, 1988

    CAS  PubMed  Google Scholar 

  10. Walker S, Rudolph G, Raedsch R, Stiehl A: Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage. Gastroenterology 102:810–815, 1992

    CAS  PubMed  Google Scholar 

  11. Sauer P, Benz C, Rudolph G, Kloeters-Plachky P, Stremmel W, Stiehl A: Influence of cholestasis on absorption of ursodeoxycholic acid. Dig Dis Sci 44:817–822, 1999

    Article  CAS  PubMed  Google Scholar 

  12. Fedorowski T, Salen G, Colallilo A, Tint GS, Mosbach EH, Hall JC: Metabolism of ursodeoxycholic acid in man. Gastroenterology 73:1131–1137, 1977

    CAS  PubMed  Google Scholar 

  13. Fedorowski T, Salen G, Tint GS, Mosbach E: Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria. Gastroenterology 77:1068–1073, 1979

    CAS  PubMed  Google Scholar 

  14. Fromm H, Carlson GL, Hofmann AF, Farivar S, Amin P: Metabolism in man of 7-ketolithocholic acid: precursor of cheno- and ursodeoxycholic acid. Am J Physiol 239:G161–G166, 1980

    CAS  PubMed  Google Scholar 

  15. Stiehl A, Raedsch R, Rudolph G: Acute effects of ursodeoxycholic acid and chenodeoxycholic acid on the small intestinal absorption of bile acids. Gastroenterology 98:424–428, 1990

    CAS  PubMed  Google Scholar 

  16. Marteau P, Chazouilleres O, Myara A, Jian R, Rambaud JC, Poupon R: Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man. Hepatology 12:1206–1208, 1990

    CAS  PubMed  Google Scholar 

  17. Combes B, Carithers RL, Maddrey WC, Munoz S, Garcia-Tsao G, Bonner GF, Boyer JL, Luketic VA, Shiffman ML, Peters MG, White H, Zetterman RK, Risser R, Rossi SS, Hofmann AF: Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 29:1649–1654, 1999

    Article  CAS  PubMed  Google Scholar 

  18. Invernizzi P, Setchell KDR, Crosignani A, Battezzati PM, Larghi A, O’Conell N, Podda M: Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. Hepatology 29:320–327, 1999

    Article  CAS  PubMed  Google Scholar 

  19. Batta AK, Salen G, Arora R, Shefer S, Tint GS, Abroon J, Eskreis D, Katz S: Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. Hepatology 10:414–419, 1989

    CAS  PubMed  Google Scholar 

  20. Crosignani A, Battezzati PM, Bertolini M, Zuin M, Watson D, Setchell KDR: Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology 14:1000–1007, 1991

    Article  CAS  PubMed  Google Scholar 

  21. Rost D, Rudolph G, Kloeters-Plachky P, Stiehl A: Effect of high dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology 40:693–698, 2004

    Article  CAS  PubMed  Google Scholar 

  22. Stiehl A, Raedsch R, Rudolph G, Czygan P, Walker S: Analysis of bile acid glucuronides in urine: group separation on a lipophilic anion exchanger. Clin Chim Acta 123:275–285, 1982

    Article  CAS  PubMed  Google Scholar 

  23. Alme B, Bremmelgaard A, Sjövall J, Thomassen P: Analysis of metabolic profiles of bile acid in urine using lipophilic anion exchanger and computerized gas liquid chromatography mass spectrometry. J Lipid Res 18:339–361, 1977

    CAS  PubMed  Google Scholar 

  24. Palma J, Reyes H, Ribalta J, Iglesias J, Gonzalez MC, Hernandez I, Alvarez C, Molina C, Danitz AM: Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 15:1043–1047, 1992

    CAS  PubMed  Google Scholar 

  25. Cotting J, Lentze MJ, Reichen J: Effects of ursodeoxycholic acid therapy on nutrition and liver function in patients with cystic fibrosis and long- standing cholestasis. Gut 31:918–921, 1990

    CAS  PubMed  Google Scholar 

  26. Colombo C, Setchell KDR, Podda M, Crosignani A, Roda A, Curcio L, Ronchi M, Giunta A: Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatr 117:482–489, 1990

    CAS  PubMed  Google Scholar 

  27. Kitani K, Kitani S: Tauroursodeoxycholate prevents taurocholate-induced cholestasis. Life Sci 30:515–523, 1982

    Article  CAS  PubMed  Google Scholar 

  28. Galle PR, Theilmann L, Raedsch R, Otto G, Stiehl A: Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 12:486–491, 1990

    CAS  PubMed  Google Scholar 

  29. Heuman DM, Mills AS, McCall J, Hylemon PB, Pandak M, Vlahcevic ZR: Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts: in vivo studies in rat. Gastroenterology 100:203–211, 1991

    CAS  PubMed  Google Scholar 

  30. Tsukahara K, Kanai S, Ohta M, Kitani K: Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats. Liver 13:262–269, 1993

    CAS  PubMed  Google Scholar 

  31. Heuman DM, Dajaj R: Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. Gastroenterology 106:1333–1341, 1994

    CAS  PubMed  Google Scholar 

  32. Benz C, Angermueller S, Töx U, Kloeters-Plachky P, Riedel HP, Sauer P, Stremmel W, Stiehl A: Effect of tauroursodeoxycholic acid on bile acid induced apoptosis and cytolysis in rat hepatocytes. J Hepatol 28:99–106, 1998

    Article  CAS  PubMed  Google Scholar 

  33. Rodrigues CM, Ma X, Linehan-Stieers C, Fan G, Kren BT, Steer J: Ursodeoxycholic acid prevents cytochrome C release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ 6:842–854, 1999

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Heidelberg, Heidelberg, Germany

    D. Rost MD, G. Rudolph MECH TECH, P. Kloeters-Plachky MECH TECH & A. Stiehl MD

  2. Medizinische Universitätsklinik, Im Neuenheimer Feld 410, D-69120, Heidelberg, Germany

    A. Stiehl MD

Authors
  1. D. Rost MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Rudolph MECH TECH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Kloeters-Plachky MECH TECH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Stiehl MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Stiehl MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rost, D., Rudolph, G., Kloeters-Plachky, P. et al. Effect of Colitis and Ileoanal Pouch on Biliary Enrichment of Ursodeoxycholic Acid in Primary Sclerosing Cholangitis. Dig Dis Sci 51, 618–622 (2006). https://doi.org/10.1007/s10620-006-3180-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-3180-5

Key Words

Search

Navigation